In vivo evidence for dendritic cell lysis by NK cells: Hints on improving cancer vaccines by targeting NK cell activation

OncoImmunology

Volumn 1, Issue 9, 2012, Pages 1635-1636

  Ferlazzo, Guido ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

Cancer vaccines; Cytotoxic T lymphocytes; Dendritic cells; Lymph nodes; Natural killer cells; Perforin

Indexed keywords

CANCER VACCINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR7; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PERFORIN; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; CANCER IMMUNOTHERAPY; CELL ACTIVATION; CELL DIFFERENTIATION; CELL MATURATION; CYTOLYSIS; CYTOTOXIC LYMPHOCYTE; DENDRITIC CELL; DRUG TARGETING; IMMUNE RESPONSE; IMMUNOGENICITY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NATURAL KILLER CELL; NONHUMAN; NOTE; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR CELL;

EID: 84886945673     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/onci.21682     Document Type: Note

References (10)

1. Ferlazzo G, Tsang ML, Moretta L, Melioli G, Steinman RM, Münz C. Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J Exp Med 2002; 195:343-51; PMID:11828009; http://dx.doi.org/10.1084/jem.20011149.
2. Ferlazzo G, Münz C. Dendritic cell interactions with NK cells from different tissues. J Clin Immunol 2009; 29:265-73; PMID:19280325; http://dx.doi.org/10.1007/s10875-009-9283-y.
3. Martín-Fontecha A, Thomsen LL, Brett S, Gerard C, Lipp M, Lanzavecchia A, et al. Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. Nat Immunol 2004; 5:1260-5; PMID:15531883; http://dx.doi.org/10.1038/ni1138.
4. Ferlazzo G. Natural killer and dendritic cell liaison: recent insights and open questions. Immunol Lett 2005; 101:12-7; PMID:15941591; http://dx.doi.org/10.1016/j.imlet.2005.04.015.
5. Moretta A. Natural killer cells and dendritic cells: rendezvous in abused tissues. Nat Rev Immunol 2002; 2:957-64; PMID:12461568; http://dx.doi. org/10.1038/nri956.
6. Langenkamp A, Messi M, Lanzavecchia A, Sallusto F. Kinetics of dendritic cell activation: impact on priming of TH1, TH2 and nonpolarized T cells. Nat Immunol 2000; 1:311-6; PMID:11017102; http://dx.doi.org/10.1038/79758.
7. Byrne P, McGuirk P, Todryk S, Mills KH. Depletion of NK cells results in disseminating lethal infection with Bordetella pertussis associated with a reduction of antigen-specific Th1 and enhancement of Th2, but not Tr1 cells. Eur J Immunol 2004; 34:2579- 88; PMID:15307190; http://dx.doi.org/10.1002/eji.200425092.
8. Andrews DM, Scalzo AA, Yokoyama WM, Smyth MJ, Degli-Esposti MA. Functional interactions between dendritic cells and NK cells during viral infection. Nat Immunol 2003; 4:175-81; PMID:12496964; http://dx.doi.org/10.1038/ni880.
9. Mocikat R, Braumüller H, Gumy A, Egeter O, Ziegler H, Reusch U, et al. Natural killer cells activated by MHC class I(low) targets prime dendritic cells to induce protective CD8 T cell responses. Immunity 2003; 19:561-9; PMID:14563320; http://dx.doi.org/10.1016/S1074-7613(03)00264-4.
10. Morandi B, Mortara L, Chiossone L, Accolla RS, Mingari MC, Moretta L, et al. Dendritic cell editing by activated natural killer cells results in a more protective cancer-specific immune response. PLoS One 2012; 7:e39170; PMID:22723958; http://dx.doi.org/10.1371/journal.pone.0039170.